Bringing the fundamentals into focus…
Back to Neumora Therapeutics, Inc.
How Neumora Therapeutics, Inc. stacks up
NMRA · against 109 other Healthcare companies of similar size
Profitability
15/ 100
Below the middle of the pack.
Ranked #75 of 110 · scores higher than 29% of peers
Bars: peers in each 10-point band of the profitability score21 peers with a profitability score of 10–19, including NMRA · Click a bar to see the companies
Why profitability scores 15?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on invested capital, which is weaker than most Healthcare peers.
- a lower return on invested capital: weaker than 98% of peers. Return on invested capital: -411.1% vs peer median 4.7%
- Operating margin is not reported, so it is left out of the score.
- a higher return on assets: stronger than 100% of peers. Return on assets: 208.5% vs peer median 1.7%
Metric by metric
Position: dot = NMRA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | NMRA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 79 reported | -411.1% | -13.2% | 6% | 33% | |
| Operating marginHigher is better · 100 reported | Not reported | -6.1% | — | — | 33% |
| Return on assetsHigher is better · 116 reported | 208.5% | -6.8% | 100% | 33% | |
| Return on equityHigher is better · 106 reported | -187.1% | -12.3% | 7% | Context only | |
| Gross marginHigher is better · 118 reported | 0.0% | 42.3% | 7% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around NMRA| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 2 | 592M ILS (≈$160M) | 96 | 84 | |
| 3 | 157M USD | 95 | ||
| 4 | 144.4B KRW (≈$104M) | 88 | 56 | |
| 5 | 244.2B KRW (≈$176M) | 83 | 72 | |
| 72 | 142M USD | 17 | 45 | |
| 74 | 83.4B KRW (≈$60M) | 16 | 36 | |
| 75 | 115M USD | 15 | 8 | |
| 75 | 109M USD | 15 | 47 | |
| 75 | 107M USD | 15 | 31 | |
| 75 | 139M USD | 15 | 32 | |
| 79 | 186M USD | 14 | 43 | |
| 79 | 170M USD | 14 | 35 | |
| 81 | 198M USD | 13 | 10 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score